Stock Track | NovoCure Soars 5.13% Intraday After Evercore ISI Raises Price Target to $20

Stock Track
May 01

NovoCure's stock soared 5.13% in intraday trading on Friday, following positive analyst action.

Evercore ISI Group raised its price target on NovoCure to $20 from $16 and maintained an Outperform rating on the shares, indicating increased confidence in the company's prospects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10